PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Sodium hyaluronate - Dry eyes

PAD Profile : Sodium hyaluronate - Dry eyes Important

Keywords :
Tear deficiency, dry-eyes, eye lubricants, ocular lubricants, dry eye disease, dry eye syndrome
Brand Names Include :
Eyeaze, VIZhyal, Hylo-Tear, Hy-Opti, Clinitas Multi
Important Information :
Moderate dry eye. Prescribe by brand (primary care)

Traffic Light Status

Status 1 of 1.

Status :
Green
Important
Formulations :
  • Eye drops
  • Eye drops (preservative free)
Important Information :
1st line: Eyeaze preservative free (0.1%, 0.2%, 0.4%) VIZhyal preservative free (0.1%, 0.2%, 0.4%) 2nd line: Hy-Opti 0.2% Clinitas Multi preservative free (0.2%, 0.4%)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date
Guidelines (Local)
Dry Eyes - Prescribing Guide for Ocular Lubricants - Aug-2023
03 June 2026
Patient resource
Eye drops patient information leaflet
03 June 2026
Information
Dry Eyes - QIPP / switch recommendations - Aug-2023
03 June 2026

Committee Recommendations

Date
Committee Name
Narrative
07 June 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Moderate dry eye.

Sodium hyaluronate eye drops / preservative free eye drops should be prescribed by brand:

1st line:
Eyeaze preservative free (0.1%, 0.2%, 0.4%)
VIZhyal preservative free (0.1%, 0.2%, 0.4%)

2nd line:
Hy-Opti 0.2%
Clinitas Multi preservative free (0.2%, 0.4%)

Associated BNF Codes

11. Eye
11.08.01. Tear deficiency, eye lubricant and astringent
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More